337 related articles for article (PubMed ID: 17975478)
21. Vasodilator mRNA levels are increased in the livers of portal hypertensive NO-synthase 3-deficient mice.
Biecker E; Sägesser H; Reichen J
Eur J Clin Invest; 2004 Apr; 34(4):283-9. PubMed ID: 15086360
[TBL] [Abstract][Full Text] [Related]
22. [Hyperdynamic circulation in patients with liver cirrhosis and portal hypertension].
Kim MY; Baik SK
Korean J Gastroenterol; 2009 Sep; 54(3):143-8. PubMed ID: 19844149
[TBL] [Abstract][Full Text] [Related]
23. Hydrogen sulphide and the hyperdynamic circulation in cirrhosis: a hypothesis.
Ebrahimkhani MR; Mani AR; Moore K
Gut; 2005 Dec; 54(12):1668-71. PubMed ID: 16174660
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic alterations in liver cirrhosis.
La Villa G; Gentilini P
Mol Aspects Med; 2008; 29(1-2):112-8. PubMed ID: 18177931
[TBL] [Abstract][Full Text] [Related]
25. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis.
Møller S; Bendtsen F
Liver Int; 2018 Apr; 38(4):570-580. PubMed ID: 28921803
[TBL] [Abstract][Full Text] [Related]
26. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
[TBL] [Abstract][Full Text] [Related]
27. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
[TBL] [Abstract][Full Text] [Related]
28. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
[TBL] [Abstract][Full Text] [Related]
29. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
[TBL] [Abstract][Full Text] [Related]
30. Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
Hennenberg M; Trebicka J; Buecher D; Heller J; Sauerbruch T
Liver Int; 2009 Jul; 29(6):933-41. PubMed ID: 19490424
[TBL] [Abstract][Full Text] [Related]
31. Haemodynamic changes in portal hypertension: new insights in the pathogenesis and clinical implications.
Michielsen PP; Pelckmans PA
Acta Gastroenterol Belg; 1994; 57(2):194-205. PubMed ID: 8053307
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and splanchnic vascular resistance.
Wiest R; Groszmann RJ
Semin Liver Dis; 1999; 19(4):411-26. PubMed ID: 10643626
[TBL] [Abstract][Full Text] [Related]
33. Current concepts on the role of nitric oxide in portal hypertension.
Hu LS; George J; Wang JH
World J Gastroenterol; 2013 Mar; 19(11):1707-17. PubMed ID: 23555159
[TBL] [Abstract][Full Text] [Related]
34. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
Wiest R; Groszmann RJ
Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
[No Abstract] [Full Text] [Related]
35. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
Gatta A; Bolognesi M; Sacerdoti D; Merkel C
Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
[TBL] [Abstract][Full Text] [Related]
36. Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.
Lluch P; Segarra G; Medina P
World J Gastroenterol; 2015 Aug; 21(32):9466-75. PubMed ID: 26327755
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide and portal hypertension.
González-Abraldes J; García-Pagán JC; Bosch J
Metab Brain Dis; 2002 Dec; 17(4):311-24. PubMed ID: 12602508
[TBL] [Abstract][Full Text] [Related]
38. [Circulatory dysfunction syndrome associated with liver cirrhosis].
Hartleb M
Przegl Epidemiol; 2005; 59(2):549-58. PubMed ID: 16190566
[TBL] [Abstract][Full Text] [Related]
39. Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.
Iwakiri Y
Liver Int; 2012 Feb; 32(2):199-213. PubMed ID: 21745318
[TBL] [Abstract][Full Text] [Related]
40. [Nitric oxide, vasodilatation and cirrhosis: a double (dys)equilibrium].
Sogni P; Moreau R; Lebrec D
Gastroenterol Clin Biol; 1999 Jan; 23(1):101-4. PubMed ID: 10219610
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
